Delivery Order SPE2DB20D3103-SPE2DB25FP1Q0
Award Date
6/12/25
Potential Completion Date
6/13/25
Potential Value
$1.5K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of MENQUADFI VIAL 0.5ML, a pharmaceutical product, with a firm-fixed price of $1,452.90 and a completion date of June 12, 2025. The contract is not set aside for any particular business category. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of MENQUADFI VIAL 0.5ML medical products. The firm-fixed-price contract has a ceiling value of $22,854.50 and a completion date of January 12, 2023. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 through November 2026, which serves as the primary vehicle for...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, which is not set aside, is for the delivery of MENQUADFI VIAL 0.5ML medical supplies with a ceiling value of $5,085.08 and a performance period ending on May 30, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of MENQUADFI VIAL 0.5ML medical products, with a firm fixed price of $8,717.28 and a completion date of June 17, 2025. The contract is not set-aside and was awarded on June 16, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of MENQUADFI VIAL 0.5ML medical products. The contract has a ceiling value of $7,024.80 and an ultimate completion date of September 9, 2024. This award is a firm fixed-price delivery order with no set-aside designation. Amerisourcebergen holds several Indefinite Delivery Contracts (IDCs) with federal agencies, including a $999,999,999 IDC with...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of MENQUADFI VIAL 0.5ML, a medical product, with a ceiling value of $102,006.68 and a performance period ending on June 26, 2024. The contract is a Firm Fixed Price type and does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a significant...
This is a delivery order federal contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of MENQUADFI VIAL 0.5ML medical products, with a firm fixed-price ceiling value of $23,954.10. The contract has an ultimate completion date of May 19, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, with a ceiling value of $7,257.70, is for the procurement of MENQUADFI VIAL 0.5ML medical products. The contract has a firm fixed price pricing type and an ultimate completion date of March 13, 2025. This appears to be a task order under a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for MENQUADFI VIAL 0.5ML. The contract is a firm fixed-price, non-set-aside award with a ceiling value of $7,264.40 and a period of performance ending on June 4, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999.00. This IDC, designated as SPE2DX,...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of MENQUADFI VIAL 0.5ML medical product. The $3,213.18 contract has a completion date of July 23, 2024 and was awarded on July 22, 2024. The contract is not designated with a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026, which...